Fatal experiments: a maverick surgeon strikes back
By Nell Frizzell,
The Guardian
| 10. 25. 2016
“If I had the choice between a transplant of a synthetic trachea and the firing squad I’d choose the last option because this is the least painful form of execution,” says Professor Pierre Delaere.
At times, the language in Fatal Experiments: the Downfall of a Supersurgeon is far from clinical. The documentary, which sparked controversy in Sweden earlier this year and which airs on the BBC this week, slices open the somewhat murky story of Paolo Macchiarini – a brilliant surgeon accused of falsifying scientific results and being investigated over potential charges akin to manslaughter, after attempts to implant plastic windpipes failed and patients died.
In the documentary, we watch archive footage of Macchiarini operate on a young Russian woman with a non-fatal condition; we see him pose for photos alongside apparently “saved” patients; we watch him take phone calls on the beach, holding his shoes; we hear from the families of patients who have died; we hear from the doctors who complained about his methods; we read the disputed extracts from his research papers and, finally, we watch...
Related Articles
By Judd Boaz and Elise Kinsella, ABC News | 03.17.2026
By Gabriele Pichlhofer and Tino Plümecke, Guest Contributors
| 03.25.2026
A German translation of this interview will be published in May 2026 in the German GID MAGAZIN, which focuses on the market for reproductive technologies. For more information, visit: Gen-ethisches Netzwerk
Egg donation is currently prohibited in Germany and Switzerland, but both countries have been debating its legalization for years. In Switzerland, a legal framework is currently being developed, with a first draft expected by the end of the year. Yet the debate rarely draws on scientific evidence. Instead...
By Charles Pulliam-Moore, The Verge | 03.21.2026
Like many people, director Valerie Veatch was intrigued when OpenAI first released its Sora text-to-video generative AI model to the public in 2024. Though she didn’t fully understand the technology, she was curious about what it could do, and she...
By Ritsuko Kawai, Wired | 03.14.2026
On March 6, Japan’s Ministry of Health, Labor and Welfare officially granted conditional and time-limited marketing authorization to two regenerative medical products derived from reprogrammed iPS cells, marking exactly 20 years since the creation of mouse iPS cells.These will...